Meeting
2024 ASCO Genitourinary Cancers Symposium
Comparative outcomes of radical nephroureterectomy and kidney-sparing surgery in the treatment of high-grade upper tract urothelial carcinoma.
Authors
Helen Gao
Rutgers-RWJ Medical School, Piscataway, NJ
Helen Gao , Kyle Moore , Jennifer Delgado , Anirudh Kulkarni , Benjamin Lichtbroun , Kevin J. Chua , John Pfail , Vignesh T. Packiam , David Golombos , Thomas L. Jang , Saum Ghodoussipour
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 607)
DOI
10.1200/JCO.2024.42.4_suppl.607
Abstract #
607
Poster Bd #
G13
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Prognostic factors and clinical outcomes in patients with upper tract urothelial carcinoma undergoing surgery: The Cleveland Clinic experience.
First Author: Ramsha Ahmed
Poster
2024 ASCO Annual Meeting
Tislelizumab plus intensity modulated radiotherapy in resectable hepatocellular carcinoma with macrovascular invasion: A prospective, single-arm, phase II trial.
First Author: Hongyu Pan
Poster
2024 ASCO Genitourinary Cancers Symposium
A phase II study of tislelizumab (T) monotherapy as neoadjuvant treatment for cisplatin-ineligible high risk upper tract urothelial carcinoma (UTUC).
First Author: Jiwei Huang
Poster
2024 ASCO Genitourinary Cancers Symposium
Linear muscle segmentation for metastatic renal cell carcinoma.
First Author: Edouard Nicaise